“…Over the last decade, a substantial effort has been directed towards improving this treatment. We have previously developed a method of selective protection of normal tissues for the eye, bladder, and skin (Bedwell et al , 1991; Reme et al , 1991; Roberts et al , 1991; Roberts and Dillon, 1993; Roberts et al , 1994) while allowing PDT therapy to destroy tumors. There has also been continuous development of several new classes of photosensitizers that can be excited at wavelengths longer than 640 nm, which allows deeper penetration, greater tumor specificity, and less cutaneous photosensitivity than Photofrin (Ali and van Lier, 1999; Detty et al , 2004; Nyman and Hynninen, 2004; Wainwright, 2008).…”